Incidence and Predictors of Unplanned Non-Target Lesion Revascularisation Up to Three Years After Drug-Eluting Stent Implantation: Insights From a Pooled Analysis of the RESOLUTE Global Clinical Trial Program

EuroIntervention - France
doi 10.4244/eijy15m07_07

Related search